Education
About Us
Working with TipRanks
Follow Us
Frank C. Bennett Insider Profile
4 Followers
Frank C. Bennett, EVP, Chief Scientific Officer at Ionis Pharmaceuticals, holds 80.29K shares in Ionis Pharmaceuticals (Ticker: IONS).
Frank C. Bennett Ionis Pharmaceuticals (IONS)EVP, Chief Scientific Officer
Ionis Pharmaceuticals (IONS)
EVP, Chief Scientific Officer
Ranked #84,635 out of 106,131 Corporate Insiders
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
-19.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Frank C. Bennett's holdings
Insider Roles
EVP, Chief Scientific Officer
Roles that Frank C. Bennett holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 22, 2023 - Dec 22, 2024
Return:+30.30%
The most profitable trade made by Frank C. Bennett
Frank C. Bennett's Trading History
List of latest transactions for each holding click on a transaction to see Frank C. Bennett's performance on stock
You May Also Like
Frank C. Bennett insider profile FAQ
What is the percentage of profitable transactions made by Frank C. Bennett?
The percentage of profitable transactions made by Frank C. Bennett is 67%.
What is the average return per transaction made by Frank C. Bennett?
The average return per transaction made by Frank C. Bennett is -19.70%.
What stocks does Frank C. Bennett hold?
Frank C. Bennett holds: IONS stocks.
What was Frank C. Bennett’s latest transaction?
Frank C. Bennett latest transaction was an Uninformative Buy of $3.50M.
What was Frank C. Bennett's most profitable transaction?
Frank C. Bennett’s most profitable transaction was an Informative Sell of IONS stock on December 22, 2023. The return on the trade was 30.30%.
What is Frank C. Bennett's role in Ionis Pharmaceuticals?
Frank C. Bennett's role in Ionis Pharmaceuticals is EVP, Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.